Searchable abstracts of presentations at key conferences in endocrinology

ea0089c28 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI in the Detection of MEN2A-related-pheochromocytoma

Jha Abhishek , Patel Mayank , Ling Alexander , Chen Clara C. , Millo Corina , Charles Kailah , Talvacchio Sara , Ezemobi Josephine , Herscovitch Peter , Lin Frank I. , Nilubol Naris , Taieb David , Cahid Civelek Ali , Carrasquillo Jorge , Pacak Karel

Background: Pheochromocytoma (PHEO) is a rare neuroendocrine tumor arising from chromaffin cells of adrenal gland that can cause life-threatening complications due to overproduction of catecholamines. Per EANM/SNMMI 2019 guidelines for radionuclide imaging of PHEO and paraganglioma, 18F-fluoro-L-dihydroxyphenylalanine (18F-FDOPA) is recommended as a positron emission tomography (PET) radiotracer of choice followed by 68Ga-DOTA(0)-Tyr(3)-octreot...

ea0089c29 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI the Detection of VHL-related Pheochromocytoma

Jha Abhishek , Patel Mayank , Ling Alexander , Chen Clara C. , Millo Corina , Charles Kailah , Talvacchio Sara , Ezemobi Josephine , Herscovitch Peter , Lin Frank I. , Nilubol Naris , Taieb David , Cahid Civelek Ali , Carrasquillo Jorge , Pacak Karel

Background: The purpose of this prospective study was to evaluate and compare the detection rates of 18F-L-dihydroxyphenylalanine (18F-FDOPA), 68Ga-DOTATATE, 18F-FDG, and 18F-fluorodopamine (18F-FDA) PET or positron emission tomography/computed tomography (PET/CT), computed tomography (CT), and magnetic resonance imaging (MRI) in the detection of VHL-related pheochromocytoma (PHEO).<p class="abstext...